> top > docs > PMC:7408073 > spans > 33076-33463 > annotations

PMC:7408073 / 33076-33463 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1307 120-128 Gene denotes Ang (1–9 Gene:284
1308 171-182 Gene denotes B1 receptor Gene:623
1309 215-219 Gene denotes ACE2 Gene:59272
1310 249-259 Gene denotes bradykinin Gene:3827
1311 272-282 Gene denotes bradykinin Gene:3827
1312 298-302 Gene denotes ACE2 Gene:59272
1314 98-106 Gene denotes Ang (1–7 Gene:284
1318 109-115 Gene denotes Ang II Gene:24179
1319 238-245 Chemical denotes des-Arg
1320 340-352 Chemical denotes casomorphins
1323 62-70 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T224 62-70 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T400 130-137 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T401 314-322 http://purl.obolibrary.org/obo/PR_000018263 denotes peptides

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T290 98-101 Chemical denotes Ang http://purl.obolibrary.org/obo/CHEBI_48433
T291 109-112 Chemical denotes Ang http://purl.obolibrary.org/obo/CHEBI_48433
T292 113-115 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T293 120-123 Chemical denotes Ang http://purl.obolibrary.org/obo/CHEBI_48433
T294 130-137 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T295 242-245 Chemical denotes Arg http://purl.obolibrary.org/obo/CHEBI_16467|http://purl.obolibrary.org/obo/CHEBI_29952
T297 249-259 Chemical denotes bradykinin http://purl.obolibrary.org/obo/CHEBI_3165
T298 272-282 Chemical denotes bradykinin http://purl.obolibrary.org/obo/CHEBI_3165
T299 314-322 Chemical denotes peptides http://purl.obolibrary.org/obo/CHEBI_16670

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T155 0-387 Sentence denotes Although in the present work I have supposed that most of the COVID-19 symptoms might derive from Ang (1–7), Ang II and Ang (1–9) peptide upregulation, the involvement of B1 receptor pathway suppression mediated by ACE2 metabolisation of des-Arg(9)-bradykinin to inactive bradykinin (1–7) or other ACE2-downstream peptides such as apelins, casomorphins and dynorphins cannot be rule out.